Alterations of the FHIT gene in human hepatocellular carcinoma

Cancer Research

Volumn 60, Issue 4, 2000, Pages 1049-1053

  Yuan, Bao Zhu ^a   Keck Waggoner, Catherine ^a   Zimonjic, Drazen B ^a   Thorgeirsson, Snorri S ^a   Popescu, Nicholas C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; GENE PRODUCT;

ALLELE; ARTICLE; CANCER CELL CULTURE; CHROMOSOME 3P; CHROMOSOME MAP; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; CARCINOMA, HEPATOCELLULAR; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; HUMANS; LIVER NEOPLASMS; NEOPLASM PROTEINS; PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0034652786     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ohta, M., Inoue, H. P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
2. Huebner, K., Garrison, P. N., Barnes, L. D., and Croce, C. M. The role of the FHIT/FRA3B locus in cancer. Annu. Rev. Genet., 32: 7-31, 1998.
3. Druck, T., Berk, L., and Huebner, K. FHITness and cancer. Oncol. Res., 10: 341-345, 1998.
4. Lebeau, M. M., Drabkin, H., Glover, T. W., Gemmill, R., Rassool, F. V., Mckeithan, T. W., and Smith, D. I. An FHIT tumor suppressor gene. Genes Chromosomes Cancer, 21: 281-289, 1998.
5. Siprashvili, Z., Sozzi, G., Barnes, L. D., McCue, P., Robinson, A. K., Eryomin, V., Sard, L., Tagliabue, E., Greco, A., Fusetti, L., Schwartz, G., Pierotti, M. A., Croce, C. M., and Huebner, K. Replacement of FHIT in cancer cells suppresses tumorigenicity. Proc. Natl. Acad. Sci. USA, 94: 13771-13776, 1997.
6. Mitelman, F., Mertens, F., and Johansson, B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat. Genet., 15: 417-474, 1997.
7. Zimonjic, D. B., Druck, T., Ohta, M., Kastury, K., Croce, C. M., Popescu, N. C., and Huebner, K. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. Cancer Res., 57: 1166-1170, 1997.
8. Inoue, H., Ishii, H., Alder, H., Snyder, E., Druck, T., Huebner, K., and Croce, C. M. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion. Proc. Natl. Acad. Sci. USA, 94: 14584-14589, 1997.
9. Simonetti, R. G., Camma, C., Fiorello, F., Politi, F., D'Amico, D., and Pagliro, L. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig. Dis. Sci., 36: 926-972, 1991.
10. Harris, C. C. Hepatocellular carcinogenesis: recent advances and speculations. Cancer Cells (Cold Spring Harbor), 2: 146-148, 1990.
11. Zimonjic, D. B., Keck, C. L., Thorgeirsson, S. S., and Popescu, N. C. Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. Hepatology, 29: 1208-1214, 1999.
12. Keck, C. L., Zimonjic, D. B., Yuan, B. Z., Thorgeirsson, S. S., and Popescu, N. C. Nonrandom breakpoints of unbalanced chromosome translocations in human hepatocellular carcinoma cell lines. Cancer Genet. Cytogenet., 111: 37-44, 1999.
13. Miller, M. J., and Yuan, B. Z. Semiautomated resolution of overlapping stutter patterns in genomic microsatellite analysis. Anal. Biochem., 251: 50-56, 1997.
14. Yunis, J. J., Soreng, A. L., and Bowe, A. E. Fragile sites are targets of diverse mutagens and carcinogens. Oncogene, 1: 59-69, 1987.
15. Popescu, N. C. Chromosome fragility and instability in human cancer. Crit. Rev. Oncog., 5: 121-140, 1994.
16. Wilke, C. M., Hall, B. K., Hoge, A., Paradee, W., Smith, D. I., and Glover, T. W. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum. Mol. Genet., 5. 187-195, 1996.
17. Smeets, D. F., Scheres, J. M., and Hustinx, T. W. The most common fragile site in man is 3p14. Hum. Genet., 72: 215-220, 1986.
18. Sozzi, G., Sard, L., De Gregorio, L., Marchetti, A., Musso, K., Buttitta, F., Tornielli, S., Pellegrini, S., Veronese, M. L., Manenti, G., Incarbone, M., Chella, A., Angeletti, C A., Pastorino, U., Huebner, K., Bevilaqua, G., Pilotti, S., Croce, C. M., and Pierotti, M. A. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res., 57: 2121-2123, 1997.
19. Nelson, H. H., Wiencke, J. K., Gunn, L., Wain, J. C., Christiani, D. C., and Kelsey, K. T. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. Cancer Res., 58: 1804-1807, 1998.
20. Virgilio, L., Shuster, M., Gollin, S. M., Veronese, M. L., Ohta, M., Huebner, K., and Croce, C. M. FHITgene alterations in head and neck squamous cell carcinomas Proc. Natl. Acad. Sci. USA, 93: 9770-9775, 1996.
21. Tanaka, H., Shimada, Y., Harada, H., Shinoda, M., Hatooka, S., Imamura, M., and Ishizaki, K. Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res., 58: 3429-3434, 1998.
22. Croce, C. M., Sozzi, G., and Huebner, K. Role of FHIT in human cancer. J. Clin. Oncol., 17: 1618-1624, 1999.
23. Mao, L., Lee, J. S., Kurie, J. M., Fan, Y. H., Lippman, S. M., Lee, J. J., Ro, J. Y., Broxson, A., Yu, R., Morice, R. C., Kemp, B. L., Khuri, F. R., Walsh, G. L., Hittelman, W. N., and Hong, W. K. Clonal genetic alterations in the lungs of current and former smokers. J. Natl. Cancer Inst., 89: 857-862, 1997.
24. Wistuba, I. I., Lam, S , Behrens, C., Virmani, A. K., Fong, K. M., LeRiche, J., Samet, J. M., Srivastava, S., Minna, J. D., and Gazdar, A. F. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst., 89: 1366-1373, 1997.
25. Chen, Y. J., Chen, P. H., and Chang, J. G. Aberrant FHIT transcripts in hepatocellular carcinomas. Br. J. Cancer, 77: 417-420, 1998.
26. Schlott, T., Ahrens, K., Ruschenburg, I., Reimer, S., Hartmann, H., and Droese, M. Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia. Br. J. Cancer, 80: 73-78, 1999.
27. Tokino, T., and Matsubara, K. Chromosomal sites for hepatitis B virus integration human hepatocelluar carcinoma. J. Virol., 65: 6761-6764, 1999.
28. Wang, H. P., and Rogler, C. E. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet. Cell Genet., 48: 72-78, 1988.